Recent Research Analysts’ Ratings Updates for Synopsys (SNPS)

Synopsys (NASDAQ: SNPS) recently received a number of ratings updates from brokerages and research firms:

• 12/13/2025 – Synopsys was upgraded by analysts at Wall Street Zen from a “sell” rating to a “hold” rating.
• 12/12/2025 – Synopsys had its price target raised by analysts at Morgan Stanley from $510.00 to $550.00. They now have an “overweight” rating on the stock.
• 12/11/2025 – Synopsys had its price target lowered by analysts at Piper Sandler from $630.00 to $602.00. They now have an “overweight” rating on the stock.
• 12/11/2025 – Synopsys had its price target raised by analysts at Wells Fargo & Company from $445.00 to $500.00. They now have an “equal weight” rating on the stock.
• 12/11/2025 – Synopsys had its price target raised by analysts at KeyCorp from $575.00 to $600.00. They now have an “overweight” rating on the stock.
• 12/11/2025 – Synopsys had its price target raised by analysts at JPMorgan Chase & Co. from $600.00 to $650.00. They now have an “overweight” rating on the stock.
• 12/11/2025 – Synopsys had its price target raised by analysts at Needham & Company LLC from $550.00 to $580.00. They now have a “buy” rating on the stock.
• 12/9/2025 – Synopsys was upgraded by analysts at Rosenblatt Securities from a “neutral” rating to a “buy” rating. They now have a $560.00 price target on the stock, down previously from $605.00.
• 12/8/2025 – Synopsys was upgraded by analysts at Bank of America Corporation from an “underperform” rating to a “neutral” rating. They now have a $500.00 price target on the stock, down previously from $525.00.
• 12/3/2025 – Synopsys had its price target lowered by analysts at KeyCorp from $590.00 to $575.00. They now have an “overweight” rating on the stock.
• 11/25/2025 – Synopsys had its price target lowered by analysts at Wells Fargo & Company from $550.00 to $445.00. They now have an “equal weight” rating on the stock.
• 11/25/2025 – Synopsys had its “reduce” rating reaffirmed by analysts at Wells Fargo & Company.
• 11/24/2025 – Synopsys is now covered by analysts at Citigroup Inc.. They set a “buy” rating and a $580.00 price target on the stock.
• 11/24/2025 – Synopsys is now covered by analysts at Citigroup Inc.. They set a “buy” rating and a $580.00 price target on the stock.
• 11/10/2025 – Synopsys was upgraded by analysts at Zacks Research from a “strong sell” rating to a “hold” rating.

Insiders Place Their Bets

In other Synopsys news, CAO Sudhindra Kankanwadi sold 9,873 shares of the stock in a transaction dated Monday, September 22nd. The shares were sold at an average price of $500.90, for a total transaction of $4,945,385.70. Following the sale, the chief accounting officer directly owned 20,520 shares in the company, valued at $10,278,468. This represents a 32.48% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.62% of the stock is owned by corporate insiders.

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.